Search
for
Sort by
Research 571–600 of 1000+
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Dermatological Indications: Alopecia Areata
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Dissolving microneedles for alopecia treatment
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Combined Use of Aqueous Extracts and Polysaccharides from Angelica sinensis and Platycladus orientalis Treats Androgenetic Alopecia
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Differentiating between Central Centrifugal Cicatricial Alopecia, Traction Alopecia, and Alopecia Areata in Black Patients: Photographic Examples from a Clinical Trial
- Effects of oxytocin receptor agonists on hair growth promotion
- 52309 Association of venous thromboembolism in patients with alopecia areata
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Upadacitinib for the treatment of alopecia areata – A case report
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients